Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Stewardship / Resistance Scan for Mar 29, 2021

Chris Dall for CIDRAP writes about the Access to Medicine Foundation's analysis on the access gap for paediatric medicines.

Date

29 March 2021

Included in a summary of three recent reports related to stewardship and resistance, author Chris Dall writes about the Access to Medicine Foundation's latest paediatric finding. Dall notes that according to the finding, less than 7% of the projects analysed by the 2021 Access to Medicine Index are intended for children under 12. 

The piece emphasises the urgent need for shorter waiting times for new medicines for children and highlights the untapped opportunities for pharmaceutical companies to improve access to paediatric medicines, especially for those in low- and middle-income countries.

Click to read the the full article.

Claudia Martínez

Research Programme Manager

Get in touch

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved